September 28, 2017
Onxeo announces compelling preclinical data in combination for its two innovative compounds, AsiDNA™ and belinostat
Media
September 25, 2017
Strongbridge Biopharma plc Launches the Uncovering Periodic Paralysis Genetic Testing Program
September 25, 2017
Fusion Pharmaceuticals Completes Oversubscribed Series A Financing Totaling $46 Million USD to Develop Targeted Alpha Therapeutics
September 25, 2017
Targovax granted US Patent for mutant-RAS neoantigen platform lead products
September 20, 2017
ALTIMMUNE ANNOUNCES ITS PHASE 2 FLU VACCINE TRIAL WITH NASOVAX OPEN FOR ENROLLMENT
September 20, 2017
Bonesupport™ – Data presented at the European Orthopaedic Research Society meeting highlights cerament® bone void filler (bvf) ability to elute drugs with the potential to enhance bone growth
September 19, 2017
Bonesupport appoints Jerry Chang as Executive Vice President of Research & Development
September 19, 2017
GenSight Biologics integrates the CAC® Small, CAC® Mid and Small and CAC® All-Tradable Euronext indexes
September 14, 2017
Targovax Receives 2017 Nordic Stars Award
September 13, 2017
Onxeo Grants Exclusive Worldwide License of Validive® developed for the treatment of oral severe mucositis to Monopar Therapeutics